NCT05088941View on ClinicalTrials.gov

Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 2, 2021

Conditions

Allogeneic Stem Cell TransplantationSARS-CoV2 InfectionCOVID-19

Trial Locations (1)

54500

CHRU of Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT05088941 - Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience | Biotech Hunter | Biotech Hunter